A set-point model with oscillatory behavior predicts the time course of 8-OH-DPAT-induced hypothermia.

Agonists for the 5-hydroxytryptamine (HT)(1A) receptor induce a hypothermic response that is believed to occur by lowering of the body's set-point temperature. We have developed a physiological model that can be used to predict the complex time course of the hypothermic response after administration of 5-HT(1A) agonists to rats. In the model, 5-HT(1A) agonists exert their effect by changing heat loss through a control mechanism with a thermostat signal that is proportional to the difference between measured and set-point temperature. Agonists exert their effect in a direct concentration-dependent manner, with saturation occurring at higher concentrations. On the basis of simulations, it is shown that, depending on the concentration and the intrinsic efficacy of a 5-HT(1A) agonist, the model shows oscillatory behavior. The model was successfully applied to characterize the complex hypothermic response profiles after administration of the reference 5-HT(1A) agonists R-8-hydroxy-2-(di-n-propylamino)tetralin (R-8-OH-DPAT) and S-8-OH-DPAT. This analysis revealed that the observed difference in effect vs. time profile for these two reference agonists could be explained by a difference in in vivo intrinsic efficacy.

[1]  W. Jusko,et al.  Pharmacodynamic modeling of nonsteroidal anti‐inflammatory drugs: antipyretic effect of ibuprofen , 1994, Clinical pharmacology and therapeutics.

[2]  C. de Montigny,et al.  Partial agonistic activity of R- and S-enantiomers of 8-OH-DPAT at 5-HT1A receptors. , 1996, Journal of psychiatry & neuroscience : JPN.

[3]  L. Arvidsson,et al.  Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase. , 1991, Molecular pharmacology.

[4]  M Cabanac,et al.  Temperature regulation. , 1975, Annual review of physiology.

[5]  H. Akaike.  A new look at the statistical model identification , 1974 .

[6]  Johan Gabrielsson,et al.  Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration , 1996, Clinical pharmacology and therapeutics.

[7]  N. R. Scott,et al.  The hypothalamus and thermoregulation: a review. , 1979, Poultry science.

[8]  J. Kelly,et al.  Comparative effects of serotonergic agonists withvarying efficacy at the 5-HT1A receptor on core body temperature: modification by the selective 5-HT1A receptor antagonist WAY 100635 , 1999, Journal of psychopharmacology.

[9]  R I Kitney,et al.  A nonlinear model for studying oscillations in the blood pressure control system. , 1979, Journal of biomedical engineering.

[10]  F. Plum.  Handbook of Physiology. , 1960 .

[11]  E. Zeisberger.  CENTRAL MODULATORS OF THERMOREGULATION , 1990, Journal of basic and clinical physiology and pharmacology.

[12]  Enantioselective high-performance liquid chromatographic analysis of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin. Application to a pharmacokinetic-pharmacodynamic study in rats. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[13]  T. Wehr,et al.  Serotonin 1A receptors, melatonin, and the proportional control thermostat in patients with winter depression. , 1998, Archives of general psychiatry.

[14]  J. Hardy.  The physiology of temperature regulation. , 1960, NADC-MA-. United States. Naval Air Development Center, Johnsville, Pa. Aviation Medical Acceleration Laboratory.

[15]  M. Hamon,et al.  Pharmacological and Physicochemical Properties of Pre‐Versus Postsynaptic 5‐Hydroxytryptamine1A Receptor Binding Sites in the Rat Brain: A Quantitative Autoradiographic Study , 1992, Journal of neurochemistry.

[16]  M. Millan,et al.  Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. , 1993, The Journal of pharmacology and experimental therapeutics.

[17]  H. V. Van Tol,et al.  Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. , 1990, The Journal of biological chemistry.

[18]  P. Salmi,et al.  Evidence for functional interactions between 5-HT1A and 5-HT2A receptors in rat thermoregulatory mechanisms. , 1998, Pharmacology & toxicology.

[19]  R. Lam,et al.  Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls. , 1999, Journal of affective disorders.

[20]  T. Lewander,et al.  Pharmacokinetic and pharmacodynamic studies of (R)-8-hydroxy-2-(di-n-propylamino)tetralin in the rat , 1997, European Neuropsychopharmacology.

[21]  J. Bligh.  The central neurology of mammalian thermoregulation , 1979, Neuroscience.

[22]  M Danhof,et al.  Mechanism-based pharmacokinetic-pharmacodynamic modeling of the effects of N6-cyclopentyladenosine analogs on heart rate in rat: estimation of in vivo operational affinity and efficacy at adenosine A1 receptors. , 1997, The Journal of pharmacology and experimental therapeutics.

[23]  S. Hjorth,et al.  8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists. , 1984, Journal of medicinal chemistry.

[24]  D. Bates,et al.  Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.

[25]  J. Hardy,et al.  Posterior hypothalamus and the regulation of body temperature. , 1973, Federation proceedings.

[26]  G. Bagdy,et al.  Comparison of relative potencies of i.v. and i.c.v. administered 8-OH-DPAT gives evidence of different sites of action for hypothermia, lower lip retraction and tail flicks. , 1997, European journal of pharmacology.

[27]  M Danhof,et al.  Mechanism-based pharmacokinetic-pharmacodynamic modeling of antilipolytic effects of adenosine A(1) receptor agonists in rats: prediction of tissue-dependent efficacy in vivo. , 1999, The Journal of pharmacology and experimental therapeutics.

[28]  P. Pauwels,et al.  Stimulated [35S]GTPγS binding by 5-HT1A receptor agonists in recombinant cell lines Modulation of apparent efficacy by G-protein activation state , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[29]  I A Cliffe,et al.  A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. , 1995, European journal of pharmacology.

[30]  M Danhof,et al.  Analysis of drug-receptor interactions in vivo: a new approach in pharmacokinetic-pharmacodynamic modelling. , 1997, International journal of clinical pharmacology and therapeutics.

[31]  T. Lewander,et al.  Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin. , 1996, European journal of pharmacology.

[32]  W. Jusko,et al.  Modeling of dose–response–time data: four examples of estimating the turnover parameters and generating kinetic functions from response profiles , 2000, Biopharmaceutics & drug disposition.

[33]  M Danhof,et al.  Relevance of the Application of Pharmacokinetic-Pharmacodynamic Modelling Concepts in Drug Development , 1997, Clinical pharmacokinetics.

[34]  Christopher J. Gordon,et al.  Thermal biology of the laboratory rat , 1990, Physiology & Behavior.

[35]  P. Moser,et al.  The effect of putative 5-HT1A receptor antagonists on 8-OH-DPAT-induced hypothermia in rats and mice. , 1991, European journal of pharmacology.

[36]  G. Hervey.  Hypothermia , 1973 .

[37]  H. Meltzer,et al.  Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat Evidence for opposing roles of 5-HT2 and 5-HT1A receptors , 1986, Neuropharmacology.

[38]  E. Zeisberger.  Chapter 10 Biogenic amines and thermoregulatory changes , 1998 .

[39]  J. E. Heath,et al.  Reassessment of the neural control of body temperature: importance of oscillating neural and motor components. , 1983, Comparative biochemistry and physiology. A, Comparative physiology.

[40]  Kinzo Matsumoto,et al.  5-HT1A and 5-HT2 Receptors mediate hypo- and hyperthermic effects of tryptophan in pargyline-pretreated rats , 1995, Pharmacology Biochemistry and Behavior.